Division of Cardiovascular Disease

Dana Rizk, M.D., has been appointed associate dean for Clinical Trials and Cynthia Joiner, Ph.D., MPH, R.N., has been named assistant dean for Clinical Research Operations in the Heersink School of Medicine, effective March 1, 2025. Both of these newly created roles will work closely with Senior Associate Dean for Clinical and Translational Research, Orlando Gutiérrez, M.D., to lead the Heersink School of Medicine’s efforts to advance clinical trials.

Vikas Dudeja, M.D., endowed professor in Gastrointestinal Oncology and director of the Division of Surgical Oncology, and Pankaj Arora, M.D., associate professor in the Department of Medicine in the Division of Cardiovascular Disease, have been elected to the American Society for Clinical Investigation's (ASCI) new active and international members for 2024.

UAB Heersink School of Medicine has awarded three grants for the latest annual Multi-Investigator Program Award cycle. The 2022/2023 AMC21 Multi-PI Awards, which provide grant funding of $150,000 per year for two years, were awarded to Javier Neyra, M.D., Carlos Orihuela, Ph.D., and Anna Thalacker-Mercer, Ph.D.

The UAB-led Chronic Hypertension and Pregnancy (CHAP) trial has been named one of the New England Journal of Medicine’s (NEJM) Notable Articles of 2022.

Medical Student Research Day celebrates the research accomplishments of medical students and provides them with the opportunity to present their projects to fellow students and faculty.

Four staff leaders from UAB residency programs were recently awarded certification from the Training Administrators for Graduate Medical Education (TAGME).